Welcome to the future of medicine.
At Unlearn, our purpose is to advance artificial intelligence (AI) to eliminate trial and error in medicine. Today, we are reimagining the randomized control trial (RCT) for the 21st century through TwinRCTs. A TwinRCT is an AI-powered RCT that allows more trial patients to receive the experimental treatment and takes significantly less time than a traditional RCT. Unlearn’s innovative work in AI today will reinvent how AI is applied in medicine tomorrow—and we have a
top secret plan for how to get there. We won’t be able to achieve this mission just by applying technologies created by others; the future must be invented.
Unlearn is a technology company, not a biotech company. We use computers, not pipettes. We make and use software, we don’t discover or make drugs. We believe that AI will define the future of medicine, and we aren’t deterred by naysayers or skeptics.
>> Unlearners are disciplined experimenters; we break down our big goals into smaller chunks and meet as often as necessary to track our velocity and iterate quickly.
>> Unlearners are gritty; we never give up, setbacks just make us try harder.
>> Unlearners are receptive to new ideas; in fact, we hate being stuck with the status quo.
>> Unlearners are storytellers; sharing information with each other and with the world is super important, too important to be boring. And, last but not least,
>> Unlearners are team-oriented; we put the mission first, the company second, the team third, and individuals last.
Founded in 2017 by a team of world-class machine learning scientists, we have raised venture capital from top tier investors such as Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio. We completed our $50 million Series B in April 2022. We are headquartered in San Francisco, CA and have an additional office in Boston, MA.
If our purpose and culture resonate with you, please join us.
Clinical Scientists are an essential contributor to the scientific and clinical knowledge required to build Unlearn’s cutting-edge machine learning models in different disease indications. Clinical Scientists have expertise in clinical trial designs and the ability to research and build knowledge in specific diseases. Successful candidates will have a “doer” mindset with exceptional collaborative skills and the ability to deliver positive outcomes.
Responsibilities
- Collaborate closely with the Data Science and Biostatistics Teams to inform data activities (e.g., understanding trial designs, clinical assessments, and prognostic variables).Develop internal documents to build internal knowledge for a given indication.
- Become familiar with endpoints and clinical trial designs for new target disease indications (preferably in the neuroscience/Inflammation & immunology space).Interact with stakeholders across the company to improve clinical information in internal data products.
- Interact with key opinion leaders to source insights and expertise.
Requirements
- PhD degree in a health science field, PharmD, or other relevant advanced degree in a health science field.
- At least 2+ years of experience in clinical trials (preferably in clinical trial design and execution) at a pharmaceutical, CRO or biotechnology company as a clinical scientist or related role.
- Ability to think strategically, creatively, and tactically with an interest in clinical research. Experience with Data Science and data analysis is a plus but not required
- Able to come into either our San Francisco or Boston office two to three days a week.
We offer a suite of benefits for our team members, including:
• 401k plan with generous matching
• Flexible PTO plus company holidays
• Annual company-wide break from December 24 through January 1
• Professional development budget to attend conferences or other events
• Company-subsidized medical, dental, & vision insurance plans
